Risk factor
Very high price volatility
Profitability factor
Greatly undervalued vs peers
About
Global Longlife Hospital & Research Ltd. operates as a comprehensive tertiary healthcare provider, offering a wide array of specialized medical services. The institution facilitates medical professionals by providing the essential environment and resources needed for patient treatment. Its clinical departments include, but are not limited to, acute care and emergency services, immunology and allergy, anesthesiology, bariatric procedures, burn treatment, cancer care, cardiology and vascular surgery, intensive critical care, advanced dental work and implants, as well as diabetes and endocrinology management. The company was established on January 20, 2012, and is headquartered in Ahmedabad, India.
Company Valuation
Based on key historical and expected multiples, the stock is greatly undervalued relative to its peers. Specifically, the stock is undervalued on EV/EBITDA.